Predicting acute kidney injury after radical cystectomy for muscle-invasive bladder cancer

Radical cystectomy (RC) with urinary diversion remains the gold standard for the treatment of muscle invasive tumors. RC is a major surgery associated with a high morbidity rate. Postoperative acute kidney injury (AKI) is associated with severe morbidity and mortality. In this study we attempted to identify risk factors for postoperative AKI in patients undergoing RC. A multicenter retrospective analysis was conducted among patients treated with radical cystectomy for muscle-invasive bladder cancer between 2015 and 2024. AKI was defined by Kidney Disease Improving Global Outcomes (KDIGO), within 90 days of surgery, with the occurrence of 1 of the 3 items: (1) increase in serum creatinine by ≥ 26.5 µmol/L within 48 h; (2) increase in serum creatinine ≥ 1.5-time baseline, which is known or presumed to have occurred within the prior seven days; (3) urine volume < 0.5 ml/kg/h during 6 h, KDIGO score were also recorded. Data were compared between two groups of patients: occurrence of AKI within the first 30 days of the post-operative period (AKI group) or no AKI during this period (no AKI group). We included 520 patients. The incidence of postoperative AKI was 40.38% ( n = 210). Patients with AKI were active smoker ( p = 0.03), significantly less often anemic ( p = 0.01), had a higher BMI ( p = 0.002), preoperative anemia ( p = 0.01). Duration of surgery was longer in AKI patients ( p < 0.001). AKI patients were more likely to need vasoactive agents ( p = 0.04). Independent factors associated with AKI were intraoperative blood loss (OR = 4.8 [95%CI: 3.06–6.43]; p = 0.01), duration of surgery (OR = 3.36 [95%CI: 2.9–11.19]; p = 0.0014); Preoperative anemia (OR = 2.69 [95%CI: 1.06–5.2]; p < 0.001); use of vasoactive agents (OR = 6.36, [95%CI: 6.01–36.87]; p < 0.001). Postoperative AKI was not associated with 2-year mortality ( p = 0.71). A significant number of patients experienced AKI after RC. Recognizing pre- and perioperative risk factors can identify patients where close surveillance and early intervention may help minimize renal function decline following RC.

Authors

Institutions

Publication Details

Journal
BMC Urology
Published
2026-07-27
DOI
https://doi.org/10.1186/s12894-026-02282-3
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predicting acute kidney injury after radical cystectomy for muscle-invasive bladder cancer

Kays Chaker, Mourad Hadj Slimène, Inès Chelly, Aida Khadhar et al.
BMC Urology
Bladder and Urothelial Cancer Treatments
article

Predicting acute kidney injury after radical cystectomy for muscle-invasive bladder cancer

Kays Chaker, Mourad Hadj Slimène, Inès Chelly, Aida Khadhar, Ahmed Chaabouni, Wassim Ben Chedly, Khouloud Ouertani, Ali Chakroun, Yasmine Laabidi, Wafa Elleuch, Afif Limem, Mahdi Marrak, Yassine Ouanes, Yassine Nouira, Mokhtar Bibi
article en

Abstract

Radical cystectomy (RC) with urinary diversion remains the gold standard for the treatment of muscle invasive tumors. RC is a major surgery associated with a high morbidity rate. Postoperative acute kidney injury (AKI) is associated with severe morbidity and mortality. In this study we attempted to identify risk factors for postoperative AKI in patients undergoing RC. A multicenter retrospective analysis was conducted among patients treated with radical cystectomy for muscle-invasive bladder cancer between 2015 and 2024. AKI was defined by Kidney Disease Improving Global Outcomes (KDIGO), within 90 days of surgery, with the occurrence of 1 of the 3 items: (1) increase in serum creatinine by ≥ 26.5 µmol/L within 48 h; (2) increase in serum creatinine ≥ 1.5-time baseline, which is known or presumed to have occurred within the prior seven days; (3) urine volume < 0.5 ml/kg/h during 6 h, KDIGO score were also recorded. Data were compared between two groups of patients: occurrence of AKI within the first 30 days of the post-operative period (AKI group) or no AKI during this period (no AKI group). We included 520 patients. The incidence of postoperative AKI was 40.38% ( n = 210). Patients with AKI were active smoker ( p = 0.03), significantly less often anemic ( p = 0.01), had a higher BMI ( p = 0.002), preoperative anemia ( p = 0.01). Duration of surgery was longer in AKI patients ( p < 0.001). AKI patients were more likely to need vasoactive agents ( p = 0.04). Independent factors associated with AKI were intraoperative blood loss (OR = 4.8 [95%CI: 3.06–6.43]; p = 0.01), duration of surgery (OR = 3.36 [95%CI: 2.9–11.19]; p = 0.0014); Preoperative anemia (OR = 2.69 [95%CI: 1.06–5.2]; p < 0.001); use of vasoactive agents (OR = 6.36, [95%CI: 6.01–36.87]; p < 0.001). Postoperative AKI was not associated with 2-year mortality ( p = 0.71). A significant number of patients experienced AKI after RC. Recognizing pre- and perioperative risk factors can identify patients where close surveillance and early intervention may help minimize renal function decline following RC.

BMC Urology
University of Sfax (TN), Hôpital La Rabta (TN), Military Hospital of Tunis (TN), Hopital Universitaire Habib Bourguiba (TN), Tunis El Manar University (TN)
Good health and well-being
Openalex Percentile: Top 7%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.